fem-pop

(redirected from femoropopliteal)
AcronymDefinition
fem-popfemoropopliteal (bypass surgery)
References in periodicals archive ?
ZILVER PTX POSTMARKET SURVEILLANCE STUDY OF PACLITAXEL-ELUTING STENTS FOR TREATING FEMOROPOPLITEAL ARTERY DISEASE IN JAPAN: 24-MONTH RESULTS Presenter: Hiroyoshi Yokoi, MD The paclitaxel-coated Zilver PTX stent (Cook Medical) is the first DES approved for the superficial femoral artery.
The LEVANT I trial for femoropopliteal revascularization.
Data shows that orbital atherectomy plus balloon angioplasty has a significantly lower average stenosis rate, exhibiting compelling short- and longer-term health and economic data for the use of atherectomy in the treatment of calcified femoropopliteal lesions.
However, challenges in treating long and severely calcified femoropopliteal lesions remain including the associated provisional stent rate with DCB and reintervention rates with directional atherectomy over the long-term," said Dr.
Stefan Muller-Hulsbeck, MD MAJESTIC prospective, single-arm clinical study designed to evaluate the performance of the Eluvia drug-eluting vascular stent system (Boston Scientific Corporation) for treating femoropopliteal artery lesions.
Biolux P-I is a randomized, controlled study investigating the safety and performance of Passeo-18 Lux (n=30) versus an uncoated Passeo-18 percutaneous transluminal angioplasty (PTA) catheter (n=30) in the treatment of lesions in the femoropopliteal segment of up to 200 mm long.
The LEVANT I Trial is a randomized study designed to test the safety and efficacy of the Lutonix Drug Coated Balloon Catheter in preventing restenosis in the femoropopliteal arteries.
The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac disease.
He would get the sympathectomy done in about 5 minutes and then turn it over to one of the fellows to do the femoropopliteal bypass.
The first report of the TransAtlantic Inter-Society Consensus (TASC-I) on the management of peripheral arterial disease, published in 2000, recommended endovascular therapies as the procedures of choice in patients with morphologically focal type A lesions of the iliac or femoropopliteal arteries, and surgery for their opposite--type D lesions--which are diffuse, extensive, and multilevel.